Showing 561-570 of 1645 results for "".
Cognitive Consequences of Vitamin D Deficiency
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/cognitive-consequences-of-vitamin-d-deficiency/30689/Concussion Management: What to Know Now
https://practicalneurology.com/diseases-diagnoses/tbi/concussion-management-what-to-know-now/30538/A specialist provides a comprehensive overview of the management of post-concussion symptoms.Mental Health and Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/mental-health-and-parkinsons-disease/30246/Assessing and addressing mental health in patients and care partners improves quality of life.- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/30984/Hashimoto’s Thyroiditis and Neurological Manifestations: Insights for Healthcare ProfessionalsHashimoto’s thyroiditis, also known as chronic lymphocytic thyroiditis, is an autoimmune disorder characterized by lymphocytic infiltration of the thyroid gland and elevated anti-thyroid antibodies, particu
- Is There Really a “Migraine Personality”?https://practicalneurology.com/diseases-diagnoses/headache-pain/pn0707-migraine-pdf/31148/Comorbidity Between Migraine and Psychiatric Disorders: Clinical Insights and Management StrategiesMigraine, a prevalent neurological disorder, frequently coexists with psychiatric conditions such as depression, anxiety, and personality disorders, significantly impacting patient outcomes and healthc
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31273/Recent advancements and studies in neurology offer promising insights for clinical practice. A GlaxoSmithKline-sponsored trial compared the efficacy of lamotrigine versus topiramate in 192 epilepsy patients. Results demonstrated that lamotrigine outperformed topiramate on cognitive assessments such
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0305Dementia-pdf/31478/Normal Pressure Hydrocephalus (NPH) has garnered renewed attention among healthcare professionals, partly driven by recent media coverage that has highlighted its potential as a reversible cause of dementia. In his article for *Practical Neurology*, Dr. David S. Geldmacher reflects on the unexpected
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/0105-pain-management-pdf/31506/Recent developments over the past quarter have prompted significant reconsideration of the FDA’s approach to approving and monitoring new pain medications, particularly COX-2 selective anti-inflammatory agents. The catalyst for this shift was Merck’s global withdrawal of rofecoxib (Vioxx) in Septemb
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn1007-dementia-pdf/31106/Caffeine, the most widely consumed psychoactive substance globally, continues to be a focal point in neurological research, particularly regarding its potential impact on cognitive decline and Alzheimer’s disease (AD). Recent studies presented in Practical Neurology highlight both promising and inco
- When and How to Discontinue AED Therapy in People with Epilepsyhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn1007Epilepsy-pdf/31115/Discontinuation of Antiepileptic Drugs: Balancing Benefits and RisksAntiepileptic drugs (AEDs) have been the cornerstone of seizure disorder management for over seven decades, evolving from phenobarbital to more than two dozen agents. A critical question arises when patients achieve seizure freedom: